Filling Date Form TypeDescription  
  
Data pager
 Page 1 of 9, items 1 to 13 of 115.
2019-07-128-KCurrent report, items 1.01, 2.03, 3.02, and 9.01 Acc-no: 0001388410-19-000079 (34 Act)  Size: 119 KB
2019-06-17S-8Securities to be offered to employees in employee benefit plansAcc-no: 0001388410-19-000076 (33 Act)  Size: 2 MB
2019-06-133Initial statement of beneficial ownership of securitiesAcc-no: 0001388410-19-000071 Size: 6 KB
2019-06-118-KCurrent report, items 1.01, 3.02, and 9.01 Acc-no: 0001388410-19-000070 (34 Act)  Size: 968 KB
2019-06-06S-1General form for registration of securities under the Securities Act of 1933Acc-no: 0001388410-19-000067 (33 Act)  Size: 3 MB
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]Acc-no: 0001388410-19-000058 (34 Act)  Size: 5 MB
2019-05-078-KCurrent report, items 1.01, 3.02, and 9.01 Acc-no: 0001388410-19-000047 (34 Act)  Size: 2 MB
2019-04-198-KCurrent report, items 1.01, 2.03, 3.02, and 9.01 Acc-no: 0001388410-19-000044 (34 Act)  Size: 1 MB
2019-04-098-KCurrent report, items 1.01, 2.03, 3.02, and 9.01 Acc-no: 0001388410-19-000042 (34 Act)  Size: 13 MB
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]Acc-no: 0001388410-19-000040 (34 Act)  Size: 10 MB
2019-04-018-KCurrent report, items 7.01 and 9.01 Acc-no: 0001388410-19-000034 (34 Act)  Size: 8 MB
2019-03-228-KCurrent report, items 1.01, 2.03, 3.02, and 9.01 Acc-no: 0001388410-19-000029 (34 Act)  Size: 515 KB
2019-03-198-KCurrent report, items 3.02, 3.03, 5.02, and 9.01 Acc-no: 0001388410-19-000026 (34 Act)  Size: 8 MB

Parallax Health Sciences Announces Licensing Agreement With HealthPointe Solutions 
7/18/2019 2:23:00 PM

Cognitive Artificial Intelligence and Data Analytics Combined with Outcomes Optimization for the Healthcare Market SANTA MONICA, CA, July 18, 2019 -- via NEWMEDIAWIRE.

Parallax Health Sciences Announces Directive in the Company's Artificial Intelligence Program
7/1/2019 10:00:00 AM

SANTA MONICA, CA, July 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, today announced that the Company would not pursue the development of a proprietary Artificial Intelligence (“AI”) Platform, and will acquire or license an established Artificial Intelligence technology from an established third-party technology with a strong background in health care.

Parallax Health Sciences Announces Strategic Initiative to Invite Third Party Development for its Digital Connected Health Platform Software Ecosystem
6/27/2019 10:00:00 AM

SANTA MONICA, CA, June 27, 2019 -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare.

Parallax Health Sciences Behavioral Health Division Announces the Development of Compass-ASD Version 2.0, its Data Driven Mobile Application
6/24/2019 10:00:00 AM

SANTA MONICA, CA, June 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, today announced that the Company has approved the design and development of Compass-ASD Version 2.0 mobile app and Parallax Care provider platform targeting the treatment of Autism.  In 2018, a research and reporting firm Marketdata stated the U.S. autism spectrum disorder (“ASD”) treatment market was estimated to be valued at $1.87 billion in 2017 and forecasted a 3.9% average yearly growth, to $2.23 billion by 2022. The Compass ASD 2.0 Parallax Care provider platform and Patented Reliable Evidenced Based Outcome Optimization Technology, (“REBOOT”) was developed, tested and commercially deployed, at a cost of approximately $4 million at Grafton Integrated Health Network, a 61 year old multi-state behavioral health care organization serving children, adolescents and adults since 1958.

Parallax Health Sciences Announces Initiative to Obtain a 510(K) Clearance for its Fotodigm® Enabled Remote Patient Monitoring Platform
6/20/2019 10:00:00 AM

SANTA MONICA, CA, June 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, today announced that the Company is preparing a 510(K) application to be filed with the U.S. Food and Drug Administration (“FDA”). Currently, the FDA regulates only small subsets of mHealth apps, and drug administration.

Parallax Health Sciences Deemed Prevailing Party and Anticipates Impending Judgment to Collect Recovery of Prior Attorney Fees and Expenses Incurred in Relation to Melamed Rescission Matter
6/17/2019 1:24:04 PM

SANTA MONICA, CA, June 17, 2019 -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare.

Parallax Health Sciences, Inc. Provides First Half 2019 Shareholder Update
6/11/2019 11:00:00 AM

Company Completes Corporate Realignment Program to Focus on Generating Revenues from Point of Care Businesses and Intellectual Property Monetization SANTA MONICA, CA, June.

David Appell Joins Parallax Health Sciences, Inc. as Chief Operating Officer
6/10/2019 10:00:00 AM

Mr. Appell brings over twenty years of experience in building high volume transactional-related platforms to deliver large revenue streams SANTA MONICA, CA / ACCESSWIRE / June 10, 2019 / Parallax Health ...

Parallax Health Sciences Reports First Quarter 2019 Operating and Financial Results
5/13/2019 10:00:00 AM

Revenue increased959% and a 56% reduction in expenses over prior-year period Recordscash sale for the first licensing of its technology SANTA MONICA, CA / ACCESSWIRE / May13, 2019 / Parallax Health Sciences, ...

Parallax Health Sciences to Participate at the Planet MicroCap Showcase 2019
4/25/2019 6:25:00 PM

SANTA MONICA, CA / ACCESSWIRE / April 25, 2019 / Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, announces that management ...

Parallax Health Sciences Reports 2018 Operating and Financial Results Records Net Income of $16.3 Million
4/1/2019 10:00:00 AM

Initiates $6 Million Equity Financing Company Now Positioned for Growth through Execution on Multi-faceted Strategy SANTA MONICA, CALIF / ACCESSWIRE / April 1, 2019 / Parallax Health Sciences, Inc. (OTCQB: ...

Parallax to Present at The MicroCap Conference on April 2
3/28/2019 10:00:00 AM

SANTA MONICA, CA / ACCESSWIRE / March 28, 2019 / Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, announces that management ...

Parallax Health Sciences Appoints Pete Scobell to Board of Advisors
3/5/2019 11:00:00 AM

SANTA MONICA, CA / ACCESSWIRE / March 5, 2019 / Parallax HealthSciences, Inc. (PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, announces that Pete Scobell has joined the Company's Advisory Board. Mr. Scobell brings Parallax strong leadership skills and telehealth marketing experience. Mr. Scobell is the founder and Chief Executive Officer of Valor Industries, a disruptive sports equipment manufacturer that provides protective equipment and technology for athletes worldwide.

Parallax Care Outcomes Platform Subject of MHCA 2019 Keynote Address
2/4/2019 8:25:00 PM

SANTA MONICA, CA / ACCESSWIRE / February 4, 2019 / Parallax Health Sciences, Inc. (PRLX) ("Parallax" or the "Company"), an outcomes-driven connected healthcare company, announces that Parallax's CTO, Nathaniel Bradley will deliver the keynote address at the Mental Health Corporations of America ("MHCA") Annual Conference on Wednesday, February 20, 2019 at the Opal Sands resort Clearwater Beach, Florida. "Parallax Care, our industry first outcomes optimizing platform, features a patented and reliable evidence-based outcomes optimization technology that has been integrated with Parallax's Intrinsic Code to provide interventional medical and pharmaceutical adherence management systems," stated Nathaniel Bradley, Parallax's Chief Technology Officer.

Parallax Integrates its Connected Health Platform into EZ Waiting Room App, Gains Access to 330,000 Physicians
1/28/2019 11:00:00 AM

SANTAMONICA, CA / ACCESSWIRE / January 28, 2019 / Parallax Health Sciences, Inc. (PRLX) ("Parallax" or the "Company"), an outcomes-driven connected healthcare company, announces an agreement whereby its wholly-owned subsidiary Parallax Communications, Inc. ("PCOM") will integrate its connected health platform into EZ Waiting Room's app. More than 330,000 doctors in the EZ Waiting Room network will be able to direct patients to monitor their treatments through the PCOM connected health platform.

Seasoned Healthcare Veteran Dr. Sylvan Waller Joins Parallax Health Sciences Advisory Board
12/18/2018 12:00:00 PM

SANTA MONICA, CA / ACCESSWIRE / December 17, 2018 / Parallax Health Sciences, Inc. (PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, announces that Sylvan Waller, M.D., FACEP has joined the Company's Advisory Board. Dr. Waller is a board-certified emergency medicine physician with more than 18 years of medical, financial management, business operations and executive leadership experience.

Parallax Health Sciences Shares Now Trade on the OTCQB(R) Venture Market
11/21/2018 12:00:00 PM

SANTA MONICA, CA / ACCESSWIRE / November 21, 2018 / Parallax Health Sciences, Inc. (PRLX) ("Parallax" or the "Company"), an outcome-driven connected healthcare company, is pleased to report that its common shares are now trading on the OTCQB ® Venture Market. Mr. Arena continued, "The U.S. Congress is now considering the Reducing Unnecessary Senior Hospitalization (RUSH) Act, which aims to reduce rehospitalizations using telemedicine and telehealth to improve patient care and reduce costs.

Parallax Health Sciences Reports Third Quarter Financial Results
11/15/2018 12:00:00 PM

Liabilities from continuing operations reduced by $24.5 million in Q3, and $18.2 million net income year-to-date Company positioned for future success with breakeven from operations expected by 2019 year ...

Parallax Health Sciences Names Dr. David Stark President of Parallax Diagnostics
10/12/2018 12:48:00 PM

SANTA MONICA, CA / ACCESSWIRE / October 12, 2018 / Parallax Health Sciences, Inc. (OTC PINK: PRLX) (''Parallax''), a technology-driven connected healthcare company, announces the appointment of David Stark in a dual role of President of Parallax Diagnostics, Inc. A wholly owned subsidiary of Parallax Health Sciences, Parallax Diagnostics is developing an innovative, mobile point of care testing platform for use doctors offices, and remote monitoring of patients. Parallax's Mobile immunoassay analyzer and flow through Target Cartridges are currently Patented in the US, China, Hong Kong and India and deliver laboratory-quality results inside of 10 minutes and at a reduced cost of comparable laboratory tests.

Parallax Health Sciences and Pareteum Corporation Partner to Create Healthcare Industry's First Globally Connected Direct-to-Consumer Virtual Network Operator
10/2/2018 10:30:00 AM

SANTA MONICA, CA and NEW YORK, NY / ACCESSWIRE / October 2, 2018 / Parallax Health Sciences, Inc. (OTC PINK: PRLX) (''Parallax''), a technology-driven connected healthcare company, today announced that it has partnered with Pareteum Corporation (TEUM) (''Pareteum'') to extend its remote healthcare offerings portfolio. The innovative strategy, which derives from the integration of Parallax and Pareteum's mobile platform technologies, will result in the establishment of Parallax Communications (''PCOM'') as the first remote patient care mobile virtual network operator (''MVNO'').